1. Home
  2. HPAI vs EDIT Comparison

HPAI vs EDIT Comparison

Compare HPAI & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HPAI
  • EDIT
  • Stock Information
  • Founded
  • HPAI 2023
  • EDIT 2013
  • Country
  • HPAI Singapore
  • EDIT United States
  • Employees
  • HPAI N/A
  • EDIT N/A
  • Industry
  • HPAI
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HPAI
  • EDIT Health Care
  • Exchange
  • HPAI NYSE
  • EDIT Nasdaq
  • Market Cap
  • HPAI 176.4M
  • EDIT 179.1M
  • IPO Year
  • HPAI N/A
  • EDIT 2016
  • Fundamental
  • Price
  • HPAI $4.62
  • EDIT $3.15
  • Analyst Decision
  • HPAI
  • EDIT Buy
  • Analyst Count
  • HPAI 0
  • EDIT 12
  • Target Price
  • HPAI N/A
  • EDIT $6.20
  • AVG Volume (30 Days)
  • HPAI 13.9K
  • EDIT 3.2M
  • Earning Date
  • HPAI 03-31-2025
  • EDIT 08-06-2025
  • Dividend Yield
  • HPAI N/A
  • EDIT N/A
  • EPS Growth
  • HPAI N/A
  • EDIT N/A
  • EPS
  • HPAI 0.06
  • EDIT N/A
  • Revenue
  • HPAI $31,475,664.00
  • EDIT $35,837,000.00
  • Revenue This Year
  • HPAI N/A
  • EDIT N/A
  • Revenue Next Year
  • HPAI N/A
  • EDIT N/A
  • P/E Ratio
  • HPAI $82.09
  • EDIT N/A
  • Revenue Growth
  • HPAI 47.72
  • EDIT N/A
  • 52 Week Low
  • HPAI $3.07
  • EDIT $0.91
  • 52 Week High
  • HPAI $14.74
  • EDIT $5.85
  • Technical
  • Relative Strength Index (RSI)
  • HPAI N/A
  • EDIT 62.28
  • Support Level
  • HPAI N/A
  • EDIT $2.66
  • Resistance Level
  • HPAI N/A
  • EDIT $3.58
  • Average True Range (ATR)
  • HPAI 0.00
  • EDIT 0.31
  • MACD
  • HPAI 0.00
  • EDIT 0.02
  • Stochastic Oscillator
  • HPAI 0.00
  • EDIT 58.85

About HPAI HELPORT AI LTD

Helport AI Ltd is an artificial intelligence (AI) technology company that provides software-as-a-service and AI tools to the contact center industry. The flagship product, AI Assist, is a real-time, intelligent software co-pilot for customer engagement professionals. Its AI + Business Process Outsourcing (BPO) service combines AI software with customer contact agents as a turnkey offering for enterprise customers. The company is headquartered in Singapore, with operations across Asia and North America. It provides solutions to the public sector, including insurance, wealth management, mortgage, and others.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: